Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Chafika Mazouni"'
Autor:
Lajos Pusztai, Gabriel N. Hortobagyi, Bryan T. Hennessy, Massimo Cristofanilli, Chafika Mazouni, Fabrice Andre, Attila Tordai, W. Fraser Symmans, Cornelia Liedtke, Marjorie C. Green, Ana M. Gonzalez-Angulo, Kenneth R. Hess, Jaime A. Mejia
Publikováno v:
Journal of Clinical Oncology. 41:1809-1815
PURPOSE Triple-negative breast cancer (TNBC) is defined by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2) expression. In this study, we compared response to neoadjuvant chemotherap
Autor:
Véronique Scott, Alexander Valent, Ivan Bièche, Suzette Delaloge, Mohamed Amine Bayar, I. Bouakka, Fabrice Andre, Corinne Balleyguier, Audrey Rapinat, Stefan Michiels, David Gentien, V. Leroux-Kozal, Magali Lacroix-Triki, Chafika Mazouni, Virginie Marty, Bianca Cheaib, Monica Arnedos, Benjamin Sarfati, Julien Adam
Publikováno v:
Annals of Oncology. 29:1755-1762
The cyclin-dependent kinase 4 (CDK4)/6 inhibitor Palbociclib is a new standard treatment in hormone-receptor positive breast cancer patients. No predictive biomarkers have been identified and no pharmacodynamics has properly been described so far.Pat
Autor:
Eric Lambaudie, Pierre-Emmanuel Colombo, Sophie Knight, Emile Daraï, Monique Cohen, Pauline Roux, Marie-Pierre Chauvet, Charles Coutant, Nicolas Chopin, Fabien Reyal, Eva Jouve, Chafika Mazouni, Gilles Houvenaeghel, Jean Marc Classe
Publikováno v:
Tumori
Tumori, Casa Editrice Ambrosiana, 2019, 105 (1), pp.55-62. ⟨10.1177/0300891618811282⟩
Tumori, 2019, 105 (1), pp.55-62. ⟨10.1177/0300891618811282⟩
Tumori, Casa Editrice Ambrosiana, 2019, 105 (1), pp.55-62. ⟨10.1177/0300891618811282⟩
Tumori, 2019, 105 (1), pp.55-62. ⟨10.1177/0300891618811282⟩
Objectives: To analyze axillary lymph node involvement (ALNI) rate and survival for mucinous (MC) and tubular (TC) breast carcinomas considered being of very good prognosis and for which an axillary surgical exploration could be questioned. Methods:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3afef727b9d6027d7f895b71358b509
https://hal.umontpellier.fr/hal-02459745
https://hal.umontpellier.fr/hal-02459745
Autor:
Sofia Rivera, S. Heymann, Malek Ferchiou, Céline Bourgier, Suzette Delaloge, Ariane Dunant, F.G. Riet, F. Fayard, Chafika Mazouni, Rodrigo Arriagada, M.A. Santos
Publikováno v:
European Journal of Cancer
European Journal of Cancer, Elsevier, 2017, 76, pp.45-51. ⟨10.1016/j.ejca.2017.01.022⟩
European Journal of Cancer, Elsevier, 2017, 76, pp.45-51. ⟨10.1016/j.ejca.2017.01.022⟩
International audience; This study evaluates the long-term outcomes of a retrospective cohort of breast cancer (BC) patients who had received curatively intended premastectomy radiation therapy (RT). We analysed locoregional control, disease-free sur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e332bd1b02e677845de0da44d8ecd35
https://hal.umontpellier.fr/hal-02408809
https://hal.umontpellier.fr/hal-02408809
Autor:
Fabrice Andre, M.G. Erlander, Catherine A. Schnabel, Suzette Delaloge, J. Passeron, N.C. Kesty, Chafika Mazouni, Véronique Scott, Monica Arnedos, Y. Zhang, M.C. Mathieu
Publikováno v:
Annals of Oncology. 23:2046-2052
Background The aim of neoadjuvant chemotherapy is to increase the likelihood of successful breast conservation surgery (BCS). Accurate identification of BCS candidates is a diagnostic challenge. Breast Cancer Index (BCI) predicts recurrence risk in e
Autor:
Céline Bourgier, Manel Barhi, Abir Al Ghuzlan, Chafika Mazouni, Hugo Marsiglia, Ismael Ghorbel, Suzette Delaloge, S. Heymann, Corinne Balleyguier
Publikováno v:
Radiotherapy and Oncology. 103:151-154
Even though tumor progression under neoadjuvant chemotherapy is uncommon, its locoregional management remains absolutely unclear. What is the best time for radical surgery or radiotherapy? "Rescue" chemo-radiotherapy could be a suitable radiosensitiz
Autor:
Aman U. Buzdar, Fabrice Andre, Gabriel N. Hortobagyi, Lajos Pusztai, Chafika Mazouni, B Wang, Mark Ayers, Banu Arun, Savitri Krishnamurthy
Publikováno v:
British Journal of Cancer
Collagen IV is a major component of the vascular basement membrane and may be a marker of angiogenesis. Serum levels of this protein are elevated in some human cancers. Our objectives were to compare collagen IV levels in the serum of breast cancer p
Autor:
Debby Frye, Shu Wan Kau, W. Fraser Symmans, Cornelia Liedtke, Chafika Mazouni, Marjorie C. Green, Fabrice Andre, Gabriel N. Hortobagyi, Lajos Pusztai, Ana M. Gonzalez-Angulo
Publikováno v:
Breast Cancer Research and Treatment. 108:183-190
We examined the correlation between HER2 expression and pathologic complete response (pCR) to paclitaxel/FAC (T/FAC) preoperative chemotherapy in breast cancer. Retrospective analysis of data including 534 patients treated with preoperative T/FAC was
Autor:
Francisco J. Esteva, Lajos Pusztai, Kristine Broglio, Chafika Mazouni, Angeline Hall, Herbert A. Fritsche, Massimo Cristofanilli, Gabriel N. Hortobagyi, Aman U. Buzdar, Fabrice Andre
Publikováno v:
Cancer. 109:496-501
BACKGROUND. The purpose of the study was to determine the utility of quantitation of the extracellular domain (ECD) of the HER-2/neu receptor in the serum for predicting response to treatment in patients with primary breast cancer receiving neoadjuva
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1766:197-204
Chemotherapy provides variable benefit to patients with breast cancer, with usually modest but occasionally severe side effects. Hence, there is a need to identify predictive biomarkers for its efficacy. DNA arrays have been used in this setting as p